Login to Your Account



Neuromed Raises $53.3M To Push Its Pain Program

By Trista Morrison


Wednesday, August 22, 2007
Neuromed Pharmaceuticals Inc. closed a $53.3 million Series E financing, bringing the company's running total of venture capital raised to date to more than $126 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription